Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | VIC-1911 |
Trade Name | |
Synonyms | TAS-119|TAS-2104 |
Drug Descriptions |
VIC-1911 (TAS-119) is a selective inhibitor of Aurora Kinase A, which potentially decreases tumor growth (Cancer Res 2023;83(7_Suppl):Abstract nr 429). |
DrugClasses | Aurka Inhibitors 27 |
CAS Registry Number | NA |
NCIT ID | C116068 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Docetaxel + VIC-1911 | Docetaxel VIC-1911 | 0 | 0 |
Paclitaxel + VIC-1911 | Paclitaxel VIC-1911 | 0 | 0 |
Sotorasib + VIC-1911 | Sotorasib VIC-1911 | 0 | 1 |
VIC-1911 | VIC-1911 | 0 | 3 |